全文获取类型
收费全文 | 3183篇 |
免费 | 157篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 41篇 |
妇产科学 | 44篇 |
基础医学 | 588篇 |
口腔科学 | 103篇 |
临床医学 | 186篇 |
内科学 | 811篇 |
皮肤病学 | 26篇 |
神经病学 | 175篇 |
特种医学 | 82篇 |
外科学 | 557篇 |
综合类 | 7篇 |
预防医学 | 70篇 |
眼科学 | 21篇 |
药学 | 217篇 |
中国医学 | 16篇 |
肿瘤学 | 392篇 |
出版年
2023年 | 17篇 |
2022年 | 38篇 |
2021年 | 51篇 |
2020年 | 36篇 |
2019年 | 37篇 |
2018年 | 58篇 |
2017年 | 50篇 |
2016年 | 59篇 |
2015年 | 47篇 |
2014年 | 73篇 |
2013年 | 101篇 |
2012年 | 143篇 |
2011年 | 156篇 |
2010年 | 101篇 |
2009年 | 84篇 |
2008年 | 151篇 |
2007年 | 174篇 |
2006年 | 153篇 |
2005年 | 167篇 |
2004年 | 157篇 |
2003年 | 181篇 |
2002年 | 147篇 |
2001年 | 113篇 |
2000年 | 110篇 |
1999年 | 97篇 |
1998年 | 50篇 |
1997年 | 36篇 |
1996年 | 30篇 |
1995年 | 21篇 |
1994年 | 29篇 |
1993年 | 21篇 |
1992年 | 61篇 |
1991年 | 64篇 |
1990年 | 44篇 |
1989年 | 47篇 |
1988年 | 35篇 |
1987年 | 54篇 |
1986年 | 61篇 |
1985年 | 35篇 |
1984年 | 22篇 |
1983年 | 22篇 |
1982年 | 20篇 |
1981年 | 17篇 |
1980年 | 23篇 |
1979年 | 23篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1974年 | 13篇 |
1973年 | 16篇 |
1968年 | 13篇 |
排序方式: 共有3362条查询结果,搜索用时 0 毫秒
91.
92.
Endo S Sakamoto Y Kobayashi E Nakamura A Takai T 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(38):14515-14520
Priming of cytotoxic T lymphocytes (CTLs) by dendritic cells (DCs) is crucial for elimination of pathogens and malignant cells. To activate CTLs, DCs present antigenic peptide-complexed MHC class I molecules (MHC-I) that will be recognized by the CTLs with T cell receptors and CD8 molecules. Here we show that paired Ig-like receptor (PIR)-B, an MHC-I receptor expressed on antigen-presenting cells, can regulate CTL triggering by blocking the access of CD8 molecules to MHC-I. PIR-B-deficient DCs evoked CTLs more efficiently, leading to accelerated graft and tumor rejection. PIR-B(+) non-DC transfectant cells served as less efficient stimulators and targets for CTLs than PIR-B(-) cells at the effector phase in vitro. On surface plasmon resonance analysis, PIR-B and CD8alpha alpha were revealed to compete in binding to MHC-I. Our results may provide a novel strategy for regulating CTL-mediated immunity and diseases in a sterical manner. 相似文献
93.
BACKGROUNDS: Estrogen is known to dilate the coronary vascular system mainly through nitric oxide (NO) release. However, it has not been determined whether or not this effect occurs equally throughout all stages of the female life cycle. We examined the changes in coronary flow properties in adolescent, adult and ovariectomized (OVX) female rats using the endothelial NO synthetase blocker, L-N (omega) nitroarginine (L-NNA). METHODS AND RESULTS: Female rats were divided into 3 groups: adolescent (13 weeks, n=6), adult (19 weeks, n=8) and OVX (20 weeks, n=7, 12 weeks after oophorectomy). Coronary effluent was measured using the Langendorff non-working heart model before and 15 min after the use of L-NNA. In OVX rats, coronary effluent was significantly decreased in comparison with adolescent and adult rats (adolescent vs OVX: p<0.001; adult vs OVX: p<0.05). After treatment with L-NNA, coronary effluent was significantly higher in the adolescent group compared with the adult and OVX groups (adolescent vs adult: p<0.01; adolescent vs OVX: p<0.0005). CONCLUSIONS: Oophorectomy brought about an increase in coronary vascular resistance. L-NNA exacerbated coronary vascular resistance in relation to maturation. It is suggested that the effect of estrogen on vascular dilatation in adolescents is largely dependent on a non-NO pathway, whereas adults are largely dependent on an NO pathway. 相似文献
94.
One possible means of driving antigen‐specific immune suppression is to expand or induce antigen‐specific FoxP3‐expressing Treg cells. One way of activating and expanding these specialized cells, both in vitro and in vivo, is by strong costimulation via CD28 with an agonistic anti‐CD28 monoclonal antibody, called anti‐CD28 superagonist (CD28SA). However, CD28SA also strongly activates conventional T (Tconv) cells to secrete proinflammatory cytokines and, under certain conditions, causes serious cytokine release syndrome. In this issue of European Journal of Immunology, Tabares et al. [Eur. J. Immunol. 2014. 44: 1225–1236] address how CD28SA can be used for the differential control of human Treg and Tconv cells to suppress immune responses without serious adverse effects. They show that, depending on the dose of the antibody or by comedication of cortico‐steroid, the selective expansion of Treg cells can be achieved without significantly activating Tconv cells to produce inflammatory cytokines. This difference in CD28 signal sensitivity between the two populations can be exploited for better control of immune responses. 相似文献
95.
96.
97.
DJ Elzi Y Lai M Song K Hakala ST Weintraub Y Shiio 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(30):12052-12057
Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescence-inducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence. 相似文献
98.
Ito K Kuno A Ikehara Y Sugiyama M Saito H Aoki Y Matsui T Imamura M Korenaga M Murata K Masaki N Tanaka Y Hige S Izumi N Kurosaki M Nishiguchi S Sakamoto M Kage M Narimatsu H Mizokami M 《Hepatology (Baltimore, Md.)》2012,56(4):1448-1456
Assessment of liver fibrosis in patients with chronic hepatitis C (CHC) is critical for predicting disease progression and determining future antiviral therapy. LecT-Hepa, a new glyco-marker derived from fibrosis-related glyco-alteration of serum alpha 1-acid glycoprotein, was used to differentiate cirrhosis from chronic hepatitis in a single-center study. Herein, we aimed to validate this new glyco-marker for estimating liver fibrosis in a multicenter study. Overall, 183 CHC patients were recruited from 5 liver centers. The parameters Aspergillus oryzae lectin (AOL) / Dature stramonium lectin (DSA) and Maackia amurensis lectin (MAL)/DSA were measured using a bedside clinical chemistry analyzer in order to calculate LecT-Hepa levels. The data were compared with those of seven other noninvasive biochemical markers and tests (hyaluronic acid, tissue inhibitor of metalloproteases-1, platelet count, aspartate aminotransferase-to-platelet ratio index [APRI], Forns index, Fib-4 index, and Zeng's score) for assessing liver fibrosis using the receiver-operating characteristic curve. LecT-Hepa correlated well with the fibrosis stage as determined by liver biopsy. The area under the curve (AUC), sensitivity, and specificity of LecT-Hepa were 0.802, 59.6%, and 89.9%, respectively, for significant fibrosis; 0.882, 83.3%, and 80.0%, respectively, for severe fibrosis; and 0.929, 84.6%, and 88.5%, respectively, for cirrhosis. AUC scores of LecT-Hepa at each fibrosis stage were greater than those of the seven aforementioned noninvasive tests and markers. Conclusion: The efficacy of LecT-Hepa, a glyco-marker developed using glycoproteomics, for estimating liver fibrosis was demonstrated in a multicenter study. LecT-Hepa given by a combination of the two glyco-parameters is a reliable method for determining the fibrosis stage and is a potential substitute for liver biopsy. (HEPATOLOGY 2012). 相似文献
99.
100.
Omental patch repair effectively treats perforated marginal ulcer following Roux-en-Y gastric bypass
Mark R. Wendling John G. Linn Kara M. Keplinger Dean J. Mikami Kyle A. Perry W. Scott Melvin Bradley J. Needleman 《Surgical endoscopy》2013,27(2):384-389